Completed NA INTERVENTIONAL 2-arm NCT02834078

Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome (Glucogold)

Effect of 'Berberine Glucogold' [BGG] on Glucose Metabolism in Individuals With Marginally Impaired Glucose Metabolism Along With Other Markers of Metabolic Syndrome

Sponsor: Healthy Directions, LLC

Conditions Pre Diabetes

Interventions BGG Placebo

Updated 5 times since 2017 Last updated: Jul 12, 2016 Started: Sep 30, 2015 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02834078, this NA trial focuses on Pre Diabetes and remains completed. Sponsored by Healthy Directions, LLC, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Healthy Directions, LLC
Vedic Lifesciences Pvt. Ltd.

Data source: Vedic Lifesciences Pvt. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.